Kinespir Patch

Diclofenac sodium, the active ingredient in Kinespir Patch, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a transdermal patch for cutaneous use. It treats localized musculoskeletal pain, osteoarthritis, rheumatoid arthritis and soft‑tissue injuries in adults.

GNH USA supplies Kinespir Patch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with the product originating from the European Union market. All batches comply with EU GMP requirements and undergo rigorous quality testing before distribution. The company ensures traceability and provides regulatory documentation to support import processes.

Diclofenac sodium is a topical NSAID that reduces inflammation and pain in musculoskeletal conditions.

Localised musculoskeletal pain: provides targeted analgesia and decreases inflammation at the application site. Osteoarthritis: relieves joint pain and improves mobility in affected joints. Rheumatoid arthritis: helps control inflammatory joint discomfort and swelling. Soft‑tissue injuries: eases pain and inflammation in sprains, strains and bruises. Post‑operative joint pain: assists in managing pain after orthopedic procedures.

Topical application of diclofenac sodium may cause skin‑related reactions and, in rare cases, systemic adverse events.

Common Side Effects: - Skin irritation at the application site. - Redness (erythema). - Itching (pruritus). - Burning sensation.

Serious or Rare Side Effects: - Allergic dermatitis or severe skin reactions such as Stevens‑Johnson syndrome. - Gastrointestinal ulceration or bleeding. - Renal or hepatic dysfunction.

When using Kinespir Patch, consider the following precautions to minimize risks and ensure safe therapy.

- Assess renal function: avoid use in patients with severe renal impairment. - Evaluate cardiovascular risk: use cautiously in individuals with history of heart disease or hypertension. - Avoid concurrent oral NSAIDs: combined use increases risk of systemic adverse effects. - Use with caution in hepatic disease: monitor liver enzymes if underlying liver dysfunction exists. - Monitor for skin reactions: discontinue if severe dermatitis develops. - Store at room temperature: keep in original packaging, protect from moisture and direct heat.

Diclofenac sodium may interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - Lithium therapy: diclofenac can raise lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Methotrexate: may increase methotrexate toxicity. - Corticosteroids: combined use may heighten risk of ulceration. - SSRIs or SNRIs: may modestly increase bleeding tendency.